Mark Cuban expresses excitement for Yusimry’s availability on MCCPDC
Mark Cuban Cost Plus Drug Company (MCCPDC) announced it is working with global biosimilar company Coherus Biosciences, Inc. to sell Yusimry, a biosimilar version of the top-selling drug Humira, at a discounted price. Yusimry is…
Continue Reading
